• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射免疫球蛋白在川崎病中的免疫作用。

The immunologic effects of IVIG in Kawasaki disease.

作者信息

Leung D Y

机构信息

Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Int Rev Immunol. 1989;5(2):197-202. doi: 10.3109/08830188909061987.

DOI:10.3109/08830188909061987
PMID:8691053
Abstract

Kawasaki disease (KD) is an acute febrile illness of early childhood that is associated with the development of coronary artery aneurysms in 15-25% of the cases. The acute phase of KD is characterized by a deficiency of suppressor T cells, marked activation of the immune system and increased secretion of cytokines by immune effector cells. Evidence that this immune activation contributes to the vascular endothelial cell damage in KD is suggested by the observation that patients in the acute phase of KD have circulating antibodies lytic for vascular endothelial cells activated with gamma interferon, IL-1 or tumor necrosis factor. In contrast, sera from these patients do not lyse unstimulated endothelial cells. High dose intravenous gammaglobulin (IVGG) treatment is effective in preventing the occurrence of coronary artery abnormalities in KD. Patients treated with IVGG have a significant increase in T suppressor cells, a decrease in circulating activated T helper cells, and a decrease in spontaneous IgG and IgM synthesis. These observations suggest that IVGG reduces the vasculitis in KD by suppressing the marked immune activation associated with this disease.

摘要

川崎病(KD)是一种幼儿期急性发热性疾病,15%至25%的病例会并发冠状动脉瘤。KD急性期的特征是抑制性T细胞缺乏、免疫系统显著激活以及免疫效应细胞分泌细胞因子增加。KD急性期患者循环中存在可裂解经γ干扰素、白细胞介素-1或肿瘤坏死因子激活的血管内皮细胞的抗体,这一观察结果提示这种免疫激活与KD的血管内皮细胞损伤有关。相比之下,这些患者的血清不能裂解未受刺激的内皮细胞。大剂量静脉注射丙种球蛋白(IVGG)治疗可有效预防KD患者冠状动脉异常的发生。接受IVGG治疗的患者中,抑制性T细胞显著增加,循环中活化的辅助性T细胞减少,自发性IgG和IgM合成减少。这些观察结果表明,IVGG通过抑制与该疾病相关的显著免疫激活来减轻KD中的血管炎。

相似文献

1
The immunologic effects of IVIG in Kawasaki disease.静脉注射免疫球蛋白在川崎病中的免疫作用。
Int Rev Immunol. 1989;5(2):197-202. doi: 10.3109/08830188909061987.
2
Clinical and immunologic aspects of Kawasaki disease.川崎病的临床与免疫学方面
Immunodefic Rev. 1989;1(3):261-71.
3
Immunomodulation by intravenous immune globulin in Kawasaki disease.
J Allergy Clin Immunol. 1989 Oct;84(4 Pt 2):588-93; discussion 593-4. doi: 10.1016/0091-6749(89)90195-4.
4
The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease.细胞因子介导的血管内皮激活在川崎病发病机制中的潜在作用。
Acta Paediatr Jpn. 1991 Dec;33(6):739-44. doi: 10.1111/j.1442-200x.1991.tb02602.x.
5
Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.川崎病的选择性高剂量γ-球蛋白治疗:临床情况及成本效益评估
Pediatr Int. 1999 Feb;41(1):1-7. doi: 10.1046/j.1442-200x.1999.01014.x.
6
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.静脉注射丙种球蛋白对川崎病体内淋巴细胞活化的逆转作用。
J Clin Invest. 1987 Feb;79(2):468-72. doi: 10.1172/JCI112835.
7
Kawasaki Disease: Beyond IVIG and Aspirin.川崎病:超越静脉注射免疫球蛋白和阿司匹林
Pediatr Ann. 2019 Oct 1;48(10):e400-e405. doi: 10.3928/19382359-20190919-01.
8
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.高剂量阿司匹林与贫血相关,且对川崎病的疾病转归无益处。
PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603. eCollection 2015.
9
Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白治疗后自然调节性T细胞的精细特异性
Autoimmunity. 2015 May;48(3):181-8. doi: 10.3109/08916934.2015.1027817. Epub 2015 Mar 30.
10
Immunological abnormalities and endothelial cell injury in Kawasaki disease.川崎病中的免疫异常与内皮细胞损伤
Acta Paediatr Jpn. 1991 Dec;33(6):752-5. doi: 10.1111/j.1442-200x.1991.tb02604.x.

引用本文的文献

1
Ultrasound evaluation of endothelial dysfunction in immunoglobulin-resistant children with acute Kawasaki disease.免疫球蛋白抵抗型川崎病患儿内皮功能障碍的超声评估。
Clin Rheumatol. 2022 Dec;41(12):3797-3805. doi: 10.1007/s10067-022-06341-6. Epub 2022 Aug 18.
2
Elevated Serum Levels of IL-21 in Kawasaki Disease.川崎病患者血清白介素-21 水平升高。
Allergy Asthma Immunol Res. 2012 Nov;4(6):351-6. doi: 10.4168/aair.2012.4.6.351. Epub 2012 Jun 29.
3
Epidemiology and management of Kawasaki disease.川崎病的流行病学和管理。
Drugs. 2012 May 28;72(8):1029-38. doi: 10.2165/11631440-000000000-00000.
4
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.大剂量静脉注射免疫球蛋白(IVIG)治疗对炎性肌病患者肌肉组织分子表达的作用有限。
Ann Rheum Dis. 2007 Oct;66(10):1276-83. doi: 10.1136/ard.2006.058644. Epub 2007 Feb 2.
5
Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.印度北部一组儿童川崎病急性期后自身抗体谱的研究。
Rheumatol Int. 2006 Jun;26(8):693-6. doi: 10.1007/s00296-005-0050-y. Epub 2005 Nov 25.
6
Functional properties of antiendothelial cell antibodies.
Clin Rev Allergy Immunol. 1998 Fall;16(3):297-302. doi: 10.1007/BF02737639.
7
Intravenous immune globulins. A review of their uses in selected immunodeficiency and autoimmune diseases.
Drugs. 1992 Jan;43(1):6-14. doi: 10.2165/00003495-199243010-00002.